Showing results (1-10 of 321) with videos related to
Sort By:
Pageof 33
Immunogenetics|August 9, 2001
HLA expression in cancer: implications for T cell-based immunotherapyA Sette, R Chesnut, J FikesJournal of Immunology (Baltimore, Md. : 1950)|July 7, 2001
Identification of new epitopes from four different tumor-associated antigens: recognition of naturally processed epitopes correlates with HLA-A*0201-binding affinityE Keogh, J Fikes, S Southwood, et al.Biologicals : Journal of the International Association of Biological Standardization|February 20, 2002
The development of multi-epitope vaccines: epitope identification, vaccine design and clinical evaluationA Sette, B Livingston, D McKinney, et al.Tissue Antigens|November 26, 2002
Optimizing vaccine design for cellular processing, MHC binding and TCR recognitionA Sette, M Newman, B Livingston, et al.Idrugs : the Investigational Drugs Journal|August 13, 2005
HLA-binding peptides as a therapeutic approach for chronic HIV infectionA Sette, R Chesnut, B Livingston, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1990
Identification of an HSV-1/HSV-2 cross-reactive T cell determinantS F Grammer, A Sette, S Colón, et al.Human Immunology|December 22, 1999
Immunization with the HBV core 18-27 epitope elicits CTL responses in humans expressing different HLA-A2 supertype moleculesB D Livingston, C Crimi, J Fikes, et al.Vaccine|September 6, 2001
Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccinesB D Livingston, M Newman, C Crimi, et al.The Journal of Experimental Medicine|September 19, 2001
Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptideS Tangri, G Y Ishioka, X Huang, et al.Molecular Immunology|December 1, 1994
Identification of potential CTL epitopes of tumor-associated antigen MAGE-1 for five common HLA-A allelesE Celis, J Fikes, P Wentworth, et al.Pageof 33